In 2020, Bucalo et al. published a study in which paradoxical psoriasis turned out to affect 16 out of 53 evaluated patients (30.2%) suffering of an IBD and treated with an anti-TNF biologic drug. The gene discussed is TNF; the disease is inflammatory bowel disease.